Holger Hebart

4PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 19, 2026
Development of a prognostic scoring system for chronic myeloid leukemia in blast phase.

Michael Lauseker, Tomasz Sacha, Hana Klamova

|Nov 27, 2024
Ibrutinib in Early-Stage Chronic Lymphocytic Leukemia: The Randomized, Placebo-Controlled, Double-Blind, Phase III CLL12 Trial.

Petra Langerbeins, Sandra Robrecht, Pascal Nieper

|Mar 29, 2024
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry.

Annamaria Brioli, Elza Lomaia, Christian Fabisch

|Jan 29, 2019
Prospective Observational Cohort Study to Describe the Use of Panitumumab in Combination with Chemotherapy in Real-World Clinical Practice for Patients with Wild-Type RAS mCRC.

Holger Hebart, Michael Kiehl, Jiri Tomasek

Pageof 1

Frequent Collaborators

2 joint publications

Susanne Saussele

2 joint publications

Georg-Nikolaus Franke

2 joint publications

Annamaria Brioli

2 joint publications

Elza Lomaia